论文部分内容阅读
与06年医药板块跑输大盘相反,2007年以来医药板块跑赢大盘。面对未来行业光明的发展前景,最佳独立见解分析师罗(青鸟)指出-随着行业集中度不断提高,医药板块将成长出大市值公司。在当前市场整体估值高企时,建议聚焦主营业务增长。
In contrast to the pharmaceutical sector underperformed the broader market in 2006, the pharmaceutical sector outperformed the broader market in 2007. In the face of a bright future for the industry, Luo (青鸟), the best independent opinion analyst, pointed out - As the concentration of the industry continues to rise, the pharmaceutical sector will grow into a large-cap company. In the current overall market valuation is high, the proposed focus on growth in the main business.